Skip to main content

Recursion Pharmaceuticals, Inc.

RXRX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001601830

In the last 90 days, Recursion Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 4 sales; 344 institutions reported holding it in 13F filings for Q2 2026, worth $1.33B in total; ARK Invest is the only superinvestor holding it.

13F holders, Q2 2022

Institutional positions in Recursion Pharmaceuticals, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
133
+8 vs. Q1 2022
Shares held
106.5M
+11.6M (+12.3%) vs. Q1 2022
Total value
$861.1M
+$182.3M (+26.9%) vs. Q1 2022
New holders
29
45 more added
Sold out
21
33 more reduced

3 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q1 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting RXRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2022: 133 institutions
Q1 2021: 1 institutionQ2 2021: 75 institutionsQ3 2021: 84 institutionsQ4 2021: 126 institutionsQ1 2022: 128 institutionsQ2 2022: 133 institutionsQ3 2022: 146 institutionsQ4 2022: 144 institutionsQ1 2023: 159 institutionsQ2 2023: 158 institutionsQ3 2023: 192 institutionsQ4 2023: 199 institutionsQ1 2024: 248 institutionsQ2 2024: 270 institutionsQ3 2024: 268 institutionsQ4 2024: 316 institutionsQ1 2025: 337 institutionsQ2 2025: 333 institutionsQ3 2025: 322 institutionsQ4 2025: 335 institutionsQ1 2026: 335 institutionsQ2 2026: 344 institutions
Value heldQ2 2022: $861.1M
Q1 2021: $1.00KQ2 2021: $1.71BQ3 2021: $1.26BQ4 2021: $1.62BQ1 2022: $680.3MQ2 2022: $861.1MQ3 2022: $1.21BQ4 2022: $954.0MQ1 2023: $841.4MQ2 2023: $952.8MQ3 2023: $1.16BQ4 2023: $2.04BQ1 2024: $2.12BQ2 2024: $1.89BQ3 2024: $1.74BQ4 2024: $2.06BQ1 2025: $1.63BQ2 2025: $1.57BQ3 2025: $1.58BQ4 2025: $1.33BQ1 2026: $1.03BQ2 2026: $1.33B
Institutions holding RXRX and their total value by quarter
QuarterHoldersValue
Q2 2026344$1.33B
Q1 2026335$1.03B
Q4 2025335$1.33B
Q3 2025322$1.58B
Q2 2025333$1.57B
Q1 2025337$1.63B
Q4 2024316$2.06B
Q3 2024268$1.74B
Q2 2024270$1.89B
Q1 2024248$2.12B
Q4 2023199$2.04B
Q3 2023192$1.16B
Q2 2023158$952.8M
Q1 2023159$841.4M
Q4 2022144$954.0M
Q3 2022146$1.21B
Q2 2022133$861.1M
Q1 2022128$680.3M
Q4 2021126$1.62B
Q3 202184$1.26B
Q2 202175$1.71B
Q1 20211$1.00K

Institutions, Q2 2022

Shares, value and share of portfolio for each institution holding Recursion Pharmaceuticals, Inc.; share changes are against Q1 2022.

Institutions holding RXRX in Q2 2022
InstitutionSharesValue% of portfolioChange in sharesAction
Handelsbanken Fonder AB13,300$108.0K0.00%00.0%Unchanged
Arizona State Retirement System12,969$106.0K0.00%+2,188+20.3%Added
HSBC Holdings PLC13,071$105.0K0.00%+13,071New
Citigroup Inc12,300$100.0K0.00%−2,599−17.4%Reduced
Daiwa Securities Group Inc.12,195$99.0K0.00%+4,954+68.4%Added
SG Americas Securities, LLC11,767$96.0K0.00%+11,767New
Martingale Asset Management L P11,100$91.0K0.00%+11,100New
Vident Investment Advisory, LLC10,481$85.0K0.00%+10,481New
Janus Henderson Group PLC10,162$83.0K0.00%+10,162New
Ameritas Investment Partners, Inc.10,141$82.0K0.00%+1,233+13.8%Added
Centaurus Financial, Inc.10,023$82.0K0.01%+10,023New
Resolute Partners Group9,168$75.0K0.01%00.0%Unchanged
Metropolitan Life Insurance Co8,375$68.2K0.00%+686+8.9%Added
BDO Wealth Advisors, LLC6,082$50.0K0.01%00.0%Unchanged
Rockefeller Capital Management L.P.5,941$48.0K0.00%−6,647−52.8%Reduced
UBS Group AG4,986$41.0K0.00%−1,941−28.0%Reduced
Macquarie Group Ltd4,927$40.0K0.00%00.0%Unchanged
Tower Research Capital LLC (TRC)4,762$39.0K0.00%+1,824+62.1%Added
Itau Unibanco Holding S.A.4,678$38.0K0.00%+2,148+84.9%Added
CWM, LLC4,510$37.0K0.00%+4,510New
Signaturefd, LLC4,250$35.0K0.00%00.0%Unchanged
National Bank of Canada3,000$24.0K0.00%+3,000New
Advisor Group Holdings, Inc.2,740$22.0K0.00%−1,068−28.0%Reduced
Baldwin Brothers Inc2,751$22.0K0.00%+2,751New
Wells Fargo & Company1,386$12.0K0.00%−8,658−86.2%Reduced
Royal Bank of Canada1,012$8.00K0.00%−6,069−85.7%Reduced
Cutler Group LP1,000$8.00K0.00%−140−12.3%Reduced
Dark Forest Capital Management LP841$7.00K0.00%+841New
Activest Wealth Management186$2.00K0.00%00.0%Unchanged
New Millennium Group LLC275$2.00K0.00%+275New
Albion Financial Group120$1.00K0.00%00.0%Unchanged
Covestor Ltd32$00.00%+7+28.0%Added
Parallel Advisors, LLC29$00.00%+29New
Casdin Capital, LLC0$00.00%−548,156−100.0%Sold out
American Century Companies Inc0$00.00%−301,984−100.0%Sold out
Two Sigma Investments, LP0$00.00%−200,131−100.0%Sold out
Twinbeech Capital LP0$00.00%−174,923−100.0%Sold out
Pinz Capital Management, LP0$00.00%−142,168−100.0%Sold out
Engineers Gate Manager LP0$00.00%−82,120−100.0%Sold out
Squarepoint Ops LLC0$00.00%−56,332−100.0%Sold out
HRT Financial LP0$00.00%−53,204−100.0%Sold out
Two Sigma Advisers, LP0$00.00%−40,100−100.0%Sold out
TD Asset Management Inc0$00.00%−32,534−100.0%Sold out
Walleye Capital LLC0$00.00%−30,882−100.0%Sold out
Bayesian Capital Management, LP0$00.00%−25,700−100.0%Sold out
Mitsubishi UFJ Kokusai Asset Management Co., Ltd.0$00.00%−16,347−100.0%Sold out
Tudor Investment Corp Et Al0$00.00%−11,914−100.0%Sold out
Assenagon Asset Management S.A.0$00.00%−10,179−100.0%Sold out
TCI Wealth Advisors, Inc.0$00.00%−594−100.0%Sold out
Simplex Trading, LLC0$00.00%−397−100.0%Sold out
Captrust Financial Advisors0$00.00%−161−100.0%Sold out
Private Capital Group, LLC0$00.00%−196−100.0%Sold out
Tucker Asset Management LLC0$00.00%−30−100.0%Sold out
Ellevest, Inc.0$00.00%−19−100.0%Sold out
Teachers Retirement System of the State of Kentucky––––Not filed
Parametric Portfolio Associates LLC––––Not filed
Amalgamated Financial Corp.––––Not filed